Concepts (98)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptor, Cannabinoid, CB1 | 4 | 2016 | 68 | 1.130 |
Why?
|
| Ethanol | 5 | 2019 | 892 | 1.110 |
Why?
|
| Endocannabinoids | 2 | 2014 | 32 | 0.890 |
Why?
|
| Central Nervous System Depressants | 3 | 2019 | 182 | 0.840 |
Why?
|
| Sleep | 3 | 2022 | 263 | 0.670 |
Why?
|
| Morpholines | 3 | 2016 | 79 | 0.650 |
Why?
|
| Sleep, REM | 3 | 2019 | 93 | 0.650 |
Why?
|
| Prefrontal Cortex | 4 | 2014 | 639 | 0.640 |
Why?
|
| Benzoxazines | 2 | 2014 | 20 | 0.530 |
Why?
|
| Naphthalenes | 2 | 2014 | 47 | 0.520 |
Why?
|
| Drug Tolerance | 2 | 2012 | 80 | 0.500 |
Why?
|
| Cannabinoids | 2 | 2012 | 90 | 0.480 |
Why?
|
| Cannabinoid Receptor Modulators | 1 | 2012 | 16 | 0.430 |
Why?
|
| Receptors, Cannabinoid | 1 | 2012 | 26 | 0.430 |
Why?
|
| Alcohol-Related Disorders | 1 | 2012 | 95 | 0.390 |
Why?
|
| Calcium Signaling | 1 | 2011 | 97 | 0.390 |
Why?
|
| Mice, Inbred C57BL | 7 | 2019 | 2790 | 0.380 |
Why?
|
| Cerebral Cortex | 1 | 2014 | 415 | 0.380 |
Why?
|
| Signal Transduction | 2 | 2016 | 2688 | 0.350 |
Why?
|
| Mice | 10 | 2022 | 8472 | 0.340 |
Why?
|
| Cognition Disorders | 1 | 2011 | 342 | 0.330 |
Why?
|
| Motor Activity | 1 | 2011 | 621 | 0.310 |
Why?
|
| Neurons | 2 | 2011 | 881 | 0.300 |
Why?
|
| Electroencephalography | 2 | 2019 | 418 | 0.270 |
Why?
|
| Sleep Deprivation | 2 | 2016 | 81 | 0.250 |
Why?
|
| Substance Withdrawal Syndrome | 2 | 2022 | 435 | 0.250 |
Why?
|
| Pyrazoles | 2 | 2016 | 190 | 0.240 |
Why?
|
| Animals | 10 | 2022 | 20877 | 0.230 |
Why?
|
| Dronabinol | 1 | 2022 | 84 | 0.200 |
Why?
|
| gamma-Aminobutyric Acid | 2 | 2014 | 208 | 0.180 |
Why?
|
| Hypnotics and Sedatives | 1 | 2019 | 96 | 0.170 |
Why?
|
| Anesthesia | 1 | 2019 | 120 | 0.160 |
Why?
|
| Monoacylglycerol Lipases | 1 | 2016 | 1 | 0.140 |
Why?
|
| Drug Inverse Agonism | 1 | 2016 | 7 | 0.140 |
Why?
|
| Benzodioxoles | 1 | 2016 | 30 | 0.140 |
Why?
|
| Amidohydrolases | 1 | 2016 | 60 | 0.140 |
Why?
|
| Electrodes, Implanted | 1 | 2016 | 98 | 0.140 |
Why?
|
| Piperidines | 1 | 2016 | 123 | 0.130 |
Why?
|
| N-Methylaspartate | 2 | 2019 | 59 | 0.130 |
Why?
|
| Glycerides | 1 | 2014 | 18 | 0.120 |
Why?
|
| Inhibitory Postsynaptic Potentials | 1 | 2014 | 25 | 0.120 |
Why?
|
| TRPV Cation Channels | 1 | 2014 | 17 | 0.120 |
Why?
|
| Polyunsaturated Alkamides | 1 | 2014 | 17 | 0.120 |
Why?
|
| Glutamates | 1 | 2014 | 41 | 0.120 |
Why?
|
| Neocortex | 1 | 2014 | 17 | 0.120 |
Why?
|
| Arachidonic Acids | 1 | 2014 | 97 | 0.120 |
Why?
|
| Gene Deletion | 1 | 2014 | 235 | 0.110 |
Why?
|
| Action Potentials | 1 | 2014 | 223 | 0.110 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2019 | 1745 | 0.110 |
Why?
|
| Receptors, Calcium-Sensing | 1 | 2011 | 10 | 0.110 |
Why?
|
| Mice, Knockout | 2 | 2014 | 1692 | 0.100 |
Why?
|
| Synapses | 1 | 2014 | 222 | 0.100 |
Why?
|
| In Vitro Techniques | 1 | 2011 | 765 | 0.090 |
Why?
|
| Receptors, Melatonin | 1 | 2010 | 8 | 0.090 |
Why?
|
| Algorithms | 1 | 2016 | 1194 | 0.090 |
Why?
|
| Melatonin | 1 | 2010 | 39 | 0.090 |
Why?
|
| Dizocilpine Maleate | 1 | 2009 | 43 | 0.090 |
Why?
|
| Electrophysiology | 1 | 2009 | 160 | 0.090 |
Why?
|
| Coculture Techniques | 1 | 2009 | 147 | 0.090 |
Why?
|
| Organ Culture Techniques | 1 | 2009 | 122 | 0.090 |
Why?
|
| Motor Neurons | 1 | 2010 | 98 | 0.090 |
Why?
|
| Pyramidal Cells | 1 | 2009 | 79 | 0.090 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2009 | 128 | 0.080 |
Why?
|
| Interneurons | 1 | 2009 | 70 | 0.080 |
Why?
|
| Oxidative Stress | 2 | 2010 | 718 | 0.080 |
Why?
|
| Cognition | 1 | 2011 | 512 | 0.080 |
Why?
|
| Comorbidity | 1 | 2012 | 1425 | 0.080 |
Why?
|
| Male | 5 | 2022 | 37281 | 0.080 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2009 | 266 | 0.070 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2010 | 626 | 0.070 |
Why?
|
| Glutamic Acid | 1 | 2010 | 332 | 0.070 |
Why?
|
| Stress, Psychological | 1 | 2012 | 824 | 0.070 |
Why?
|
| Psychomotor Performance | 1 | 2005 | 213 | 0.060 |
Why?
|
| Rats | 1 | 2012 | 5300 | 0.060 |
Why?
|
| Alcoholism | 1 | 2012 | 1109 | 0.060 |
Why?
|
| Behavior, Animal | 1 | 2005 | 470 | 0.060 |
Why?
|
| Apoptosis | 1 | 2010 | 1640 | 0.060 |
Why?
|
| Carrier Proteins | 1 | 2005 | 597 | 0.050 |
Why?
|
| Cannabinoid Receptor Agonists | 1 | 2022 | 20 | 0.050 |
Why?
|
| GABA-A Receptor Agonists | 1 | 2019 | 13 | 0.050 |
Why?
|
| Dopamine | 1 | 2022 | 474 | 0.040 |
Why?
|
| Polysomnography | 1 | 2019 | 92 | 0.040 |
Why?
|
| Tryptamines | 1 | 2010 | 7 | 0.020 |
Why?
|
| Receptor, Melatonin, MT1 | 1 | 2010 | 10 | 0.020 |
Why?
|
| Receptor, Melatonin, MT2 | 1 | 2010 | 11 | 0.020 |
Why?
|
| BH3 Interacting Domain Death Agonist Protein | 1 | 2010 | 22 | 0.020 |
Why?
|
| Caspase 8 | 1 | 2010 | 40 | 0.020 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2010 | 93 | 0.020 |
Why?
|
| Hydrogen Peroxide | 1 | 2010 | 168 | 0.020 |
Why?
|
| Homer Scaffolding Proteins | 1 | 2005 | 24 | 0.020 |
Why?
|
| Calcium | 1 | 2010 | 929 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2005 | 246 | 0.020 |
Why?
|
| Humans | 1 | 2012 | 68525 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2005 | 532 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2010 | 2673 | 0.020 |
Why?
|
| Schizophrenia | 1 | 2005 | 206 | 0.020 |
Why?
|
| Memory | 1 | 2005 | 214 | 0.020 |
Why?
|
| Female | 2 | 2022 | 38015 | 0.010 |
Why?
|